Artiva Biotherapeutics (ARTV) Capital Expenditures (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported Capital Expenditures of $298000.0 for Q1 2026, down 66.21% year-over-year from $882000.0 in Q1 2025, and up 115.9% quarter-over-quarter from -$1.9 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Capital Expenditures (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Capital Expenditures data on file, last reported at $298000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $298000.0, down 66.21% year-over-year; the trailing twelve-month figure through Mar 2026 was -$292000.0 (down 131.7% YoY), and the FY2025 annual result was $292000.0, up 412.28% from the prior year.
- Capital Expenditures climbed to $298000.0 in Q1 2026 per ARTV's latest filing, from -$1.9 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $2.6 million in Q4 2023 and troughed at -$1.9 million in Q4 2025.
- A 4-year average of $132909.1 and a median of $96000.0 in 2024 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 4800.0% in 2025 and fell as far as 259.69% in 2025.
- A 4-year view of Capital Expenditures shows it stood at $2.6 million in 2023, then slumped by 119.73% to -$521000.0 in 2024, then slumped by 259.69% to -$1.9 million in 2025, then surged by 115.9% to $298000.0 in 2026.
- Business Quant data shows ARTV's Capital Expenditures at $298000.0 in Q1 2026, -$1.9 million in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | 298,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 298,000.00 |
| Mar 31, 2026 | 298,000.00 |
| Dec 31, 2025 | -1.87 Mn |
| Dec 31, 2025 | -1.87 Mn |
| Sep 30, 2025 | 1.88 Mn |
| Sep 30, 2025 | 1.88 Mn |
| Jun 30, 2025 | -599,000.00 |
| Jun 30, 2025 | -599,000.00 |
| Mar 31, 2025 | 882,000.00 |
| Mar 31, 2025 | 882,000.00 |
| Dec 31, 2024 | -521,000.00 |
| Dec 31, 2024 | -521,000.00 |
| Sep 30, 2024 | 96,000.00 |
| Sep 30, 2024 | 96,000.00 |
| Jun 30, 2024 | 464,000.00 |
| Jun 30, 2024 | 464,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Dec 31, 2023 | 2.64 Mn |
| Dec 31, 2023 | 2.64 Mn |